{{Rsnum
|rsid=2266917
|Gene=ATP6V1B1
|Chromosome=2
|position=70942575
|Orientation=plus
|GMAF=0.2759
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=AC007040.7,ATP6V1B1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 44.2 | 48.7
| HCB | 3.6 | 24.1 | 72.3
| JPT | 6.2 | 28.3 | 65.5
| YRI | 17.0 | 49.7 | 33.3
| ASW | 5.3 | 52.6 | 42.1
| CHB | 3.6 | 24.1 | 72.3
| CHD | 2.8 | 24.1 | 73.1
| GIH | 5.0 | 22.8 | 72.3
| LWK | 18.2 | 48.2 | 33.6
| MEX | 5.2 | 25.9 | 69.0
| MKK | 8.4 | 51.0 | 40.6
| TSI | 4.9 | 37.3 | 57.8
| HapMapRevision=28
}}{{PMID|19008710|OA=1
}} [[rs2266917]], located in the [[ATP6B1]] gene, passed adjustments for multiple testing and had a significant independent main effect (p = 0.0018) on diastolic [[high blood pressure]] among African-American women, based on a study of 1418 African-American women and men from the Genetic Epidemiology Network of Arteriopathy study.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}